Uveitis/Inflammatory Eye Disease
Therapy applied directly inside the eye best for treating uveitic macular edema
Delivery of corticosteroids directly into the eye is more effective than injections adjacent to the eye, according to results from a comparative clinical trial of macular edema in patients with noninfectious uveitis. The study was funded by the...
NIH researchers unleash therapeutic potential of IL-35
NIH scientists have simplified manufacturing and dosing of a potential drug candidate for the autoimmune eye disease uveitis—a vision-threatening condition that accounts for about 15 percent of blindness in the U.S. The protein in question, part...
Systemic therapy outperforms intraocular implant for treating uveitis
Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better – and had fewer adverse outcomes – than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by...
In Uveitis, Bacteria in Gut May Instruct Immune Cells to Attack the Eye
The inflammatory eye disorder autoimmune uveitis occurs when a person’s immune system goes awry, attacking proteins in the eye. What spurs this response is a mystery, but now a study on mice suggests that bacteria in the gut may provide a kind of...
New Treatment for Eye Disease Reduces Need for Strong Drugs
Researchers at the National Institutes of Health (NIH) have discovered a substance that allows people with uveitis, a potentially blinding eye disease, to stop or reduce the need for powerful drugs. A paper detailing these findings is published...
New Eye Disease Treatment May Improve Patients' Quality of Life
In a small preliminary study, researchers at the National Institutes of Health (NIH) have discovered a possible new treatment for uveitis, a potentially blinding eye disease. The new treatment allows patients to stop taking the current standard...
NIH Researchers Discover Promising New Therapy for Blinding Eye Disease
A preliminary clinical trial, conducted by researchers at the National Institutes of Health (NIH), found that an investigational treatment for uveitis (pronounced yoo-vee-eye-tis) seems to have many fewer side effects than existing therapies,...
Soothing cells, peaceful protein could hold promise for treating autoimmune uveitis
Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss.
Uveitis occurs when immune...
NIH study shows two treatments for uveitis equally effective
Treating patients with severe cases of uveitis, the fifth leading cause of vision loss in the United States, either locally with eye implants or systemically with anti-inflammatory medications improved vision similarly over two years, according...